By MoH of Ukraine orders No. 615 of 18.07.13 and No. 727 of 16.08.13, the patient information leaflets (hereinafter – the leaflet) of the original (reference) medicinal product containing clarithromycin were approved, namely of the products Klacid®, film-coated tablets, Klacid®, granules for suspension, with amendments and additions to the following sections of the leaflet: “Contraindications”, “Adverse reactions”, “Special warnings and precautions for use”, “Interaction with other medicinal products and other forms of interaction”, “Effects on ability to drive and use machines”. Klacid SR, prolonged-release film-coated tablets, with amendments and additions to the following sections of the leaflet: “Contraindications”, “Adverse reactions”, “Special warnings and precautions for use”, “Interaction with other medicinal products and other forms of interaction”.
List of medicinal products containing clarithromycin, authorized for medical use in Ukraine.
